Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00217Source: DataRank Database

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2 is a research paper published in ACS Pharmacology & Translational Science (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.44)OA: greenTopics (20)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sung-Han Hsiao,Megumi Murakami ORCID,Yang-Hui Huang,Yu‐Tzu Chang ORCID,Tai‐Ho Hung ORCID

Live enrichment

PubMed:38230272 OpenAlex:https://openalex.org/W4389362815

Ministry of Science and Technology, Taiwan

Grant: 111-2320-B-182-018

Ministry of Science and Technology, Taiwan

Grant: 109-2314-B-182A-097-MY3

Ministry of Science and Technology, Taiwan

Grant: 110-2113-M-029-006

Taichung Veterans General Hospital

Grant: TCVGH-T1107807

National Science and Technology Council

Grant: 112-2320-B-182-018

Chang Gung Memorial Hospital

Grant: BMRPC17

Chang Gung Memorial Hospital

Grant: CMRPD1M0582

FWCI

1.44

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-029

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10789147/pdf/pt3c00217.pdf

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00217

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10789147

journalhttps://doi.org/10.1021/acsptsci.3c00217

Fields of Study

Drug Transport and Resistance MechanismsCancer therapeutics and mechanismsHIV/AIDS drug development and treatment

Keywords

Abcg2ATP-binding cassette transporterMultiple drug resistancePharmacologyTyrosine-kinase inhibitorBiologyP-glycoproteinDrug repositioningIn silicoCancerCancer cellCancer researchEpidermal growth factor receptorDrug resistanceDrugTransporterBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being